Invention Grant
- Patent Title: Substituted piperazines as CB1 antagonists
- Patent Title (中): 取代的哌嗪作为CB1拮抗剂
-
Application No.: US12564678Application Date: 2009-09-22
-
Publication No.: US08236805B2Publication Date: 2012-08-07
- Inventor: Eric J. Gilbert , Michael W. Miller , Jack D. Scott , Andrew W. Stamford , William J. Greenlee , Jay Weinstein
- Applicant: Eric J. Gilbert , Michael W. Miller , Jack D. Scott , Andrew W. Stamford , William J. Greenlee , Jay Weinstein
- Applicant Address: US NJ Summit NL Boxmeer
- Assignee: Intervet Inc.,Intervet International B.V.
- Current Assignee: Intervet Inc.,Intervet International B.V.
- Current Assignee Address: US NJ Summit NL Boxmeer
- Agent David J. Kerwick
- Main IPC: A61K31/497
- IPC: A61K31/497 ; C07D403/00
Abstract:
Compounds of Formula (I): or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
Public/Granted literature
- US20100029607A1 Substituted Piperazines as CB1 Antagonists Public/Granted day:2010-02-04
Information query
IPC分类:
